StashLearn
Get the app
Get the app

Join millions of investors on Stash

Investing, simplified

Start today with as little as $5
Get the app
Money News

Why is Albertsons Purchasing Rite Aid?

February 20, 2018

  • Grocery chain Albertsons is buying the rest of drugstore chain Rite Aid
  • The deal allows Albertsons to become a public company
  • It also gives Albertsons a stake in the rapidly transforming healthcare industry
4 min read

Grocery store chain Albertsons announced Tuesday that it will purchase the remainder of independent Rite Aid stores, with the supermarket chain rebranding its own pharmacies as Rite Aid.

The deal, which will create a company worth a reported $24 billion and with annual sales potential of $83 billion, comes during a shakeup in the the world of traditional retail sales, which includes grocery and drugstore sales.

“Our combination with Rite Aid will enable us to even better serve the valuable pharmacy customer by providing a fully integrated one-stop-shop for our customers’ food, health, and wellness needs,” Bob Miller, Albertsons Companies chairman and chief executive officer, said in a press release.

Miller told the Wall Street Journal on Tuesday the merger was a way for Albertsons and Rite Aid to stay competitive against large retailers such as Walmart and online giant Amazon.

Drug stores getting a big shake up

Over the past few months, drugstore chains have been at the center of a number of big mergers and acquisitions, as different segments of the traditional retail industry struggle to redefine themselves.

In September 2017, Rite Aid sold nearly half of its 4,000 stores to Walgreens, in a deal worth $4.4 billion, according to reports. Walgreens initially proposed buying all of Rite Aid, but was blocked by regulators.

And in a move that analysts said shows how the healthcare industry is being reshaped, drugstore chain CVS announced a $70 billion deal to purchase health insurance company Aetna in December. Aetna and CVS say they’ll be able to offer low-cost care through the chain’s many locations, via apps and the phone, according to reports.

CVS and Aetna were also said by some analysts to be acting defensively, as the healthcare market gets more competitive and new entrants make a play for products and services. Amazon, for example, is said to be in talks about entering the pharmacy business.

Amazon, which is in a pitched battle with Walmart for online and grocery sales, announced in June that it would buy Whole Foods. The grocery industry as a whole is worth $800 billion and the drug industry is worth about $450 billion in the U.S., according to Bloomberg.

The healthcare market in transition

The drugstore mergers come at a time when companies and consumers are struggling to contain healthcare costs. Some market uncertainty stems from the tax overhaul, passed by Congress in December, which eliminates something called the individual mandate, a key part of Affordable Care Act, known as Obamacare. The mandate had required consumers to purchase health care or pay a tax penalty. Without that source of revenue, health care premiums could become more expensive, according to experts.

The drugstore mergers come at a time when companies and consumers are struggling to contain healthcare costs.

With those things in mind, In late January, Amazon, Berkshire Hathaway, and JPMorgan Chase announced they would pool resources to create a health care savings consortium for their 1.5 million employees.

The executives of those companies offered few details about the project, which they said is in its early stages, but they said in a press release the companies would focus “on technology solutions that will provide [their] U.S. employees and their families with simplified, high-quality and transparent health care at a reasonable cost,” as well as creating a solution “free from profit-making incentives”.

Albertsons finds a way to go public

Albertsons is owned by the private equity group Cerberus Capital, which purchased the grocery store chain in 2013 for $3.3 billion.

Cerberus had tried to bring Albertson’s public in 2015, but was unsuccessful. By purchasing Rite Aid, which is public, the private equity fund will be able to merge the grocery store chain with a company that is already public. It will do that by exchanging shares of Rite Aid Stock for Albertsons stock.

Good to know: a private equity fund pools money from wealthy individuals and other investors to purchase mature companies, usually with the intention of boosting sales and profits and then selling them at a profit. By bringing Albertson’s public through a combination with Rite Aid, Cerberus will achieve that goal by selling a portion of the company to the public.

Following the merger, which must first be approved by regulators, Albertsons and Rite Aid will have approximately 4,900 locations and 4,350 pharmacy counters, as well as 320 clinics across 38 states and Washington, D.C. They will also serve 40 million customers per week, Albertson’s said in a press release.  The combined company will be renamed following approval of the deal, Albertsons said.

News of the merger sent Rite Aid stock up 2% to $2.17 a share in early afternoon trading on Tuesday.*

Fast facts: Albertsons

Fast Facts: Rite Aid

*Source: Yahoo Finance, Tuesday, February 20, 2018

By Jeremy Quittner
Jeremy Quittner is the senior writer for Stash.

Next for you
A Healthy Merger? Why CVS Wants to Buy Aetna for $69B

Investment Profile

Bonds Worldwide

An International Bond ETF on Stash

Learn more
Explore more articlesChoose a topic to learn more about
Technology market news politics social media budgeting
Disclaimers

This material has been distributed for informational and educational purposes only, represents an assessment of the market environment as of the date of publication, is subject to change without notice, and is not intended as investment, legal, accounting, or tax advice or opinion. Stash assumes no obligation to provide notifications of changes in any factors that could affect the information provided. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. The strategies discussed are strictly for illustrative and educational purposes and should not be construed as a recommendation to purchase or sell, or an offer to sell or a solicitation of an offer to buy any security. There is no guarantee that any strategies discussed will be effective.

Furthermore, the information presented does not take into consideration commissions, tax implications, or other transactional costs, which may significantly affect the economic consequences of a given strategy or investment decision. This information is not intended as a recommendation to invest in any particular asset class or strategy or as a promise of future performance. There is no guarantee that any investment strategy will work under all market conditions or is suitable for all investors. Each investor should evaluate their ability to invest long term, especially during periods of downturn in the market. Investors should not substitute these materials for professional services, and should seek advice from an independent advisor before acting on any information presented. Before investing, please carefully consider your willingness to take on risk and your financial ability to afford investment losses when deciding how much individual security exposure to have in your investment portfolio.

Past performance does not guarantee future results. There is a potential for loss as well as gain in investing. Stash does not represent in any manner that the circumstances described herein will result in any particular outcome. While the data and analysis Stash uses from third party sources is believed to be reliable, Stash does not guarantee the accuracy of such information. Nothing in this article should be considered as a solicitation or offer, or recommendation, to buy or sell any particular security or investment product or to engage in any investment strategy. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. Stash does not provide personalized financial planning to investors, such as estate, tax, or retirement planning. Investment advisory services are only provided to investors who become Stash Clients pursuant to a written Advisory Agreement. For more information please visit www.stashinvest.com/disclosures.